BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

563 related articles for article (PubMed ID: 29462574)

  • 1. Adiponectin receptor agonist AdipoRon decreased ceramide, and lipotoxicity, and ameliorated diabetic nephropathy.
    Choi SR; Lim JH; Kim MY; Kim EN; Kim Y; Choi BS; Kim YS; Kim HW; Lim KM; Kim MJ; Park CW
    Metabolism; 2018 Aug; 85():348-360. PubMed ID: 29462574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Adiponectin Receptor Agonist AdipoRon Ameliorates Diabetic Nephropathy in a Model of Type 2 Diabetes.
    Kim Y; Lim JH; Kim MY; Kim EN; Yoon HE; Shin SJ; Choi BS; Kim YS; Chang YS; Park CW
    J Am Soc Nephrol; 2018 Apr; 29(4):1108-1127. PubMed ID: 29330340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adiponectin receptor agonist ameliorates cardiac lipotoxicity via enhancing ceramide metabolism in type 2 diabetic mice.
    Kim Y; Lim JH; Kim EN; Hong YA; Park HJ; Chung S; Choi BS; Kim YS; Park JY; Kim HW; Park CW
    Cell Death Dis; 2022 Mar; 13(3):282. PubMed ID: 35351872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resveratrol increases AdipoR1 and AdipoR2 expression in type 2 diabetic nephropathy.
    Park HS; Lim JH; Kim MY; Kim Y; Hong YA; Choi SR; Chung S; Kim HW; Choi BS; Kim YS; Chang YS; Park CW
    J Transl Med; 2016 Jun; 14(1):176. PubMed ID: 27286657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anthocyanin-rich Seoritae extract ameliorates renal lipotoxicity via activation of AMP-activated protein kinase in diabetic mice.
    Koh ES; Lim JH; Kim MY; Chung S; Shin SJ; Choi BS; Kim HW; Hwang SY; Kim SW; Park CW; Chang YS
    J Transl Med; 2015 Jun; 13():203. PubMed ID: 26116070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of Adiponectin Action: Implication of Adiponectin Receptor Agonism in Diabetic Kidney Disease.
    Kim Y; Park CW
    Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30974901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cinacalcet-mediated activation of the CaMKKβ-LKB1-AMPK pathway attenuates diabetic nephropathy in db/db mice by modulation of apoptosis and autophagy.
    Lim JH; Kim HW; Kim MY; Kim TW; Kim EN; Kim Y; Chung S; Kim YS; Choi BS; Kim YS; Chang YS; Kim HW; Park CW
    Cell Death Dis; 2018 Feb; 9(3):270. PubMed ID: 29449563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fenofibrate improves renal lipotoxicity through activation of AMPK-PGC-1α in db/db mice.
    Hong YA; Lim JH; Kim MY; Kim TW; Kim Y; Yang KS; Park HS; Choi SR; Chung S; Kim HW; Kim HW; Choi BS; Chang YS; Park CW
    PLoS One; 2014; 9(5):e96147. PubMed ID: 24801481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resveratrol prevents renal lipotoxicity and inhibits mesangial cell glucotoxicity in a manner dependent on the AMPK-SIRT1-PGC1α axis in db/db mice.
    Kim MY; Lim JH; Youn HH; Hong YA; Yang KS; Park HS; Chung S; Ko SH; Shin SJ; Choi BS; Kim HW; Kim YS; Lee JH; Chang YS; Park CW
    Diabetologia; 2013 Jan; 56(1):204-17. PubMed ID: 23090186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AdipoRon, adiponectin receptor agonist, improves vascular function in the mesenteric arteries of type 2 diabetic mice.
    Choi SK; Kwon Y; Byeon S; Haam CE; Lee YH
    PLoS One; 2020; 15(3):e0230227. PubMed ID: 32182257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adiponectin receptor agonist AdipoRon ameliorates renal inflammation in diet-induced obese mice and endotoxin-treated human glomeruli ex vivo.
    Lindfors S; Polianskyte-Prause Z; Bouslama R; Lehtonen E; Mannerla M; Nisen H; Tienari J; Salmenkari H; Forsgård R; Mirtti T; Lehto M; Groop PH; Lehtonen S
    Diabetologia; 2021 Aug; 64(8):1866-1879. PubMed ID: 33987714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipotoxicity dysregulates the immunoproteasome in podocytes and kidneys in type 2 diabetes.
    Lee HS; Suh JY; Kang BC; Lee E
    Am J Physiol Renal Physiol; 2021 Apr; 320(4):F548-F558. PubMed ID: 33586497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective Effects of Curcumin on Renal Oxidative Stress and Lipid Metabolism in a Rat Model of Type 2 Diabetic Nephropathy.
    Kim BH; Lee ES; Choi R; Nawaboot J; Lee MY; Lee EY; Kim HS; Chung CH
    Yonsei Med J; 2016 May; 57(3):664-73. PubMed ID: 26996567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renoprotective effect of a novel selective PPARα modulator K-877 in db/db mice: A role of diacylglycerol-protein kinase C-NAD(P)H oxidase pathway.
    Maki T; Maeda Y; Sonoda N; Makimura H; Kimura S; Maeno S; Takayanagi R; Inoguchi T
    Metabolism; 2017 Jun; 71():33-45. PubMed ID: 28521876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PEGylated AdipoRon derivatives improve glucose and lipid metabolism under insulinopenic and high-fat diet conditions.
    Onodera T; Ghazvini Zadeh E; Xu P; Gordillo R; Guo Z; Joffin N; Yu B; Scherer PE; Li WH
    J Lipid Res; 2021; 62():100095. PubMed ID: 34214600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AdipoRon Protects against Tubular Injury in Diabetic Nephropathy by Inhibiting Endoplasmic Reticulum Stress.
    Xiong S; Han Y; Gao P; Zhao H; Jiang N; Sun L
    Oxid Med Cell Longev; 2020; 2020():6104375. PubMed ID: 32832003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AdipoRon, an adiponectin receptor agonist, protects contrast-induced nephropathy by suppressing oxidative stress and inflammation via activation of the AMPK pathway.
    Gu D; Shi Y; Gong Z; Xia T; Ren H; He D; Yang J; Han Y; Zeng C
    Clin Exp Nephrol; 2020 Nov; 24(11):989-998. PubMed ID: 32734507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of lymphatic proliferation by the selective VEGFR-3 inhibitor SAR131675 ameliorates diabetic nephropathy in db/db mice.
    Hwang SD; Song JH; Kim Y; Lim JH; Kim MY; Kim EN; Hong YA; Chung S; Choi BS; Kim YS; Park CW
    Cell Death Dis; 2019 Mar; 10(3):219. PubMed ID: 30833548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of cannabinoid receptor 1 improves insulin resistance, lipid metabolism, and diabetic nephropathy in db/db mice.
    Nam DH; Lee MH; Kim JE; Song HK; Kang YS; Lee JE; Kim HW; Cha JJ; Hyun YY; Kim SH; Han SY; Han KH; Han JY; Cha DR
    Endocrinology; 2012 Mar; 153(3):1387-96. PubMed ID: 22234468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity.
    Okada-Iwabu M; Yamauchi T; Iwabu M; Honma T; Hamagami K; Matsuda K; Yamaguchi M; Tanabe H; Kimura-Someya T; Shirouzu M; Ogata H; Tokuyama K; Ueki K; Nagano T; Tanaka A; Yokoyama S; Kadowaki T
    Nature; 2013 Nov; 503(7477):493-9. PubMed ID: 24172895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.